Evidence map›Paper›PMID 39423276›Full record

ArticleScience advances2024

Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis.

Carlos G Ardanaz, Aida de la Cruz, Paras S Minhas, Nira Hernández-Martín, Miguel Ángel Pozo, M Pilar Valdecantos, Ángela M Valverde, Palmira Villa-Valverde, Marcos Elizalde-Horcada, Elena Puerta and 11 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Diabetes-Associated Cognitive Impairment: Pathophysiology and Emerging Therapies.Annals of clinical and translational neurology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Vacuolar protein sorting 35 regulates retinal neurovascular functionInternational journal of ophthalmology · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Carlos G ArdanazDepartment of Pharmaceutical Sciences, Division of Pharmacology, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-5328-2986
Aida de la CruzLaboratory of Local Translation in Neurons and Glia, Achucarro Basque Centre for Neuroscience, 48940 Leioa, Spain.ORCID 0000-0002-6039-8263
Paras S MinhasDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-7741-3327
Nira Hernández-MartínUnidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0009-0009-3933-1804
Miguel Ángel PozoUnidad de Cartografía Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0001-9303-0513
M Pilar ValdecantosInstituto de Investigaciones Biomédicas Sols-Morreale, CSIC-UAM, Department of Metabolism and Cellular Signaling, Madrid 28029, Spain.ORCID 0000-0002-3239-4898
Ángela M ValverdeInstituto de Investigaciones Biomédicas Sols-Morreale, CSIC-UAM, Department of Metabolism and Cellular Signaling, Madrid 28029, Spain.ORCID 0000-0003-1192-9045
Palmira Villa-ValverdeICTS Bioimagen Complutense, Universidad Complutense de Madrid, Madrid, Spain.ORCID 0000-0001-9054-9176
Marcos Elizalde-HorcadaInstitut d'Investigació Sanitaria Pere Virgili (IISPV), 43204 Reus, Spain.
Elena PuertaDepartment of Pharmaceutical Sciences, Division of Pharmacology, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-5695-5787
María J RamírezDepartment of Pharmaceutical Sciences, Division of Pharmacology, University of Navarra, 31008 Pamplona, Spain.
Jorge E OrtegaCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain.ORCID 0000-0001-8188-874X
Ainhoa UrbiolaIdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
Cristina EderraIdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.ORCID 0009-0003-9876-4657
Mikel ArizIdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.ORCID 0000-0002-7328-1582
Carlos Ortiz-de-SolórzanoIdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.ORCID 0000-0001-8720-0205
Joaquín Fernández-IrigoyenProteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, 31008 Pamplona, Spain.ORCID 0000-0001-5072-4099
Enrique SantamaríaClinical Neuroproteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, 31008 Pamplona, Spain.ORCID 0000-0001-8046-8102
Gerard KarsentyDepartment of Genetics and Development, Vagelos College of Physicians and Surgeons, Columbia University, 701 West 168th Street, New York, NY, USA.ORCID 0000-0002-9253-7627
Jens C BrüningMax Planck Institute for Metabolism Research, Department of Neuronal Control of Metabolism, 50931 Cologne, Germany.ORCID 0000-0002-6619-0092
Maite SolasDepartment of Pharmaceutical Sciences, Division of Pharmacology, University of Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-7670-3237

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Astrocytes are considered an essential source of blood-borne glucose or its metabolites to neurons. Nonetheless, the necessity of the main astrocyte glucose transporter, i.e., GLUT1, for brain glucose metabolism has not been defined. Unexpectedly, we found that brain glucose metabolism was paradoxically augmented in mice with astrocytic GLUT1 reduction (GLUT1

Indexed as

AstrocytesBrainGlucoseGlucose Transporter Type 1HomeostasisAdenosine TriphosphateAnimalsEnergy MetabolismInsulinMiceMice, KnockoutObesityReceptor, InsulinSignal TransductionAdenosine TriphosphateGlucoseGlucose Transporter Type 1InsulinReceptor, InsulinSlc2a1 protein, mouse

Identifiers

PMID39423276
PMCPMC11488540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.